drugset / Trial / NCT00020748
Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of epirubicin plus irinotecan in treating patients who have advanced cancer.
Timeline
- Start
- 2000-08
- Primary completion
- 2004-10
- Completion
- 2004-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epirubicin | Small molecule | — | Intravenous |
| Subject | Irinotecan | Small molecule | — | Intravenous |